• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻风病患者中NLRC4的研究

A Study of NLRC4 in Patients with Leprosy.

作者信息

Batta Salma Mosaad, Far Nashwa Naeem El, Soliman Nema Ali, Nassar Samia Othman

机构信息

From the Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

出版信息

Indian J Dermatol. 2023 Jul-Aug;68(4):385-392. doi: 10.4103/ijd.ijd_781_22.

DOI:10.4103/ijd.ijd_781_22
PMID:37822385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10564182/
Abstract

BACKGROUND

Activation of the NLRC4 inflammasome appears to start many signalling processes inside the host, including caspase-1, the principal protease responsible for converting proIL-1β and IL-18 to active, secreted IL-1β and IL-18, resulting in pyroptosis.

AIMS

To evaluate NLRC4 level in patient's blood serum to highlight its role in the pathogenesis of leprosy.

MATERIALS AND METHODS

This prospective study was conducted on 40 patients with leprosy and 30 healthy individuals of matched ages and sexes. All patients were subjected to complete history taking, general and dermatological examination, laboratory investigations, slit skin smear with bacillary index, and clinical classification of the studied leprosy group patients regarding disability according to disability grading. And finally, measurement of serum NLRC4 level by ELISA.

RESULTS

In the paucibacillary (PB) group, NLRC4 serum level ranged from 0.9 to 1.8 ng/ml with 1.43 ± 0.28 ng/ml, while in the multibacillary (MB) group, it ranged from 1.2 to 5.7 ng/ml with 2.83 ± 1.11 ng/ml. NLRC4 serum level had increased significantly in MB patients compared to PB patients ( < 0.05). There was a significant difference among the three studied groups, regarding the serum level of NLRC4 ( < 0.05). In leprosy patients, significant positive correlations were found between serum levels of NLRC4 and bacillary index and duration of leprosy.

CONCLUSIONS

Leprosy patients had considerably greater serum levels of NLRC4 than controls. It was much greater in MB patients than in PB patients.

摘要

背景

NLRC4炎性小体的激活似乎会启动宿主体内的许多信号传导过程,包括胱天蛋白酶-1,这是负责将前白细胞介素-1β和白细胞介素-18转化为活性分泌型白细胞介素-1β和白细胞介素-18的主要蛋白酶,从而导致细胞焦亡。

目的

评估患者血清中NLRC4水平,以突出其在麻风病发病机制中的作用。

材料与方法

本前瞻性研究对40例麻风病患者和30名年龄及性别匹配的健康个体进行。所有患者均进行了完整的病史采集、全身及皮肤科检查、实验室检查、带菌指数的皮肤涂片检查,以及根据残疾分级对研究的麻风病组患者进行残疾方面的临床分类。最后,采用酶联免疫吸附测定法(ELISA)测量血清NLRC4水平。

结果

在少菌型(PB)组中,NLRC4血清水平范围为0.9至1.8 ng/ml,平均为1.43±0.28 ng/ml,而在多菌型(MB)组中,其范围为1.2至5.7 ng/ml,平均为2.83±1.11 ng/ml。与PB患者相比,MB患者的NLRC4血清水平显著升高(<0.05)。在三个研究组之间,NLRC4血清水平存在显著差异(<0.05)。在麻风病患者中,NLRC4血清水平与带菌指数和麻风病病程之间存在显著正相关。

结论

麻风病患者血清中NLRC4水平明显高于对照组。MB患者的该水平比PB患者高得多。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/bfd9b0ea1544/IJD-68-385-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/5702119119a3/IJD-68-385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/c7556f3c8652/IJD-68-385-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/551cec82bab2/IJD-68-385-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/860c3ab4ab7c/IJD-68-385-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/9d289f653417/IJD-68-385-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/6705ef8b2981/IJD-68-385-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/bfd9b0ea1544/IJD-68-385-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/5702119119a3/IJD-68-385-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/c7556f3c8652/IJD-68-385-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/551cec82bab2/IJD-68-385-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/860c3ab4ab7c/IJD-68-385-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/9d289f653417/IJD-68-385-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/6705ef8b2981/IJD-68-385-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca63/10564182/bfd9b0ea1544/IJD-68-385-g007.jpg

相似文献

1
A Study of NLRC4 in Patients with Leprosy.麻风病患者中NLRC4的研究
Indian J Dermatol. 2023 Jul-Aug;68(4):385-392. doi: 10.4103/ijd.ijd_781_22.
2
Implications of Serum Anti-Ceramide Antibodies and Interleukin 4 on Nerve Damage and Physical Impairments Among Leprotic Patients: A Case-Controlled Study.血清抗神经酰胺抗体和白细胞介素 4 对麻风病患者神经损伤和躯体功能障碍的影响:一项病例对照研究。
J Drugs Dermatol. 2022 Mar 1;21(3):284-291. doi: 10.36849/JDD.5543.
3
Comparison of bacillary index on slit skin smear with bacillary index of granuloma in leprosy and its relevance to present therapeutic regimens.麻风病患者裂隙皮肤涂片细菌指数与肉芽肿细菌指数的比较及其与当前治疗方案的相关性。
Indian J Dermatol. 2015 Jan-Feb;60(1):51-4. doi: 10.4103/0019-5154.147791.
4
Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.麻风病患者血清中几丁质酶活性增加:与细菌型麻风病的关联。
Clin Immunol. 2009 Jun;131(3):501-9. doi: 10.1016/j.clim.2009.02.003.
5
Slit-skin smear for the classification of leprosy; are we wasting time and resource?利福平皮肤划痕试验在麻风分类中的应用;我们是否在浪费时间和资源?
J Infect Dev Ctries. 2022 Aug 31;16(8.1):3S-7S. doi: 10.3855/jidc.15992.
6
Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease.对有1至5个皮肤损害的麻风患者进行评估,以确定其分组为少菌型或多菌型疾病的相关性。
Indian J Dermatol Venereol Leprol. 2006 May-Jun;72(3):207-10. doi: 10.4103/0378-6323.25781.
7
AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.AIM2 和 NLRC4 驱动的炎症小体激活与成人Still 病,以及羧甲脒三唑的初步治疗效果探索。
Clin Rheumatol. 2023 Jun;42(6):1635-1643. doi: 10.1007/s10067-022-06443-1. Epub 2022 Nov 24.
8
Cytokines in leprosy, II. Effect of treatment on serum cytokines in leprosy.麻风病中的细胞因子,II. 治疗对麻风病患者血清细胞因子的影响。
Int J Dermatol. 1998 Oct;37(10):741-6. doi: 10.1046/j.1365-4362.1998.00382.x.
9
Shigella type III secretion protein MxiI is recognized by Naip2 to induce Nlrc4 inflammasome activation independently of Pkcδ.志贺氏菌 III 型分泌蛋白 MxiI 被 Naip2 识别,独立于 Pkcδ 诱导 Nlrc4 炎性体激活。
PLoS Pathog. 2014 Feb 6;10(2):e1003926. doi: 10.1371/journal.ppat.1003926. eCollection 2014 Feb.
10
Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.将患者分配至多菌型或少菌型药物治疗方案以治疗麻风病——主要基于皮肤涂片的方法与临床方法的比较——患者分类的替代临床方法
Int J Lepr Other Mycobact Dis. 1991 Jun;59(2):292-303.

本文引用的文献

1
Expression of NLRP3 inflammasome in leprosy indicates immune evasion of Mycobacterium leprae.NLRP3 炎性小体在麻风病中的表达表明麻风分枝杆菌的免疫逃避。
Mem Inst Oswaldo Cruz. 2020 Feb 27;115:e190324. doi: 10.1590/0074-02760190324. eCollection 2020.
2
Disabilities in leprosy: an open, retrospective analyses of institutional records.麻风病中的残疾情况:机构记录的开放性回顾性分析
An Bras Dermatol. 2020 Jan-Feb;95(1):52-56. doi: 10.1016/j.abd.2019.07.001. Epub 2019 Dec 28.
3
The inflammasome in leprosy skin lesions: an immunohistochemical evaluation.
麻风皮肤病变中的炎性小体:一项免疫组织化学评估
Infect Drug Resist. 2018 Nov 12;11:2231-2240. doi: 10.2147/IDR.S172806. eCollection 2018.
4
Contribution of the inflammasome to inflammaging.炎症小体在炎性衰老中的作用。
J Inflamm (Lond). 2018 Nov 16;15:23. doi: 10.1186/s12950-018-0198-3. eCollection 2018.
5
Whole blood profiling of leprosy type 1(reversal) reactions highlights prominence of innate immune response genes.麻风病 1 型(逆转)反应的全血分析突出了固有免疫反应基因的重要性。
BMC Infect Dis. 2018 Aug 24;18(1):422. doi: 10.1186/s12879-018-3348-6.
6
Key component of inflammasome, NLRC4, was identified in the lesional epidermis of psoriatic patients.炎症小体的关键组成部分 NLRC4 在银屑病患者的皮损表皮中被鉴定出来。
J Dermatol. 2018 Aug;45(8):971-977. doi: 10.1111/1346-8138.14478. Epub 2018 May 24.
7
Novel aspects of the assembly and activation of inflammasomes with focus on the NLRC4 inflammasome.NLRC4 炎性体:组装和激活炎性体的新方面。
Int Immunol. 2018 Apr 25;30(5):183-193. doi: 10.1093/intimm/dxy009.
8
The NLRC4 Inflammasome.NLRC4 炎症小体。
Immunol Rev. 2018 Jan;281(1):115-123. doi: 10.1111/imr.12607.
9
Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain.外周神经中NLRP3炎性小体的激活促成了紫杉醇诱导的神经性疼痛。
Mol Pain. 2017 Jan-Dec;13:1744806917719804. doi: 10.1177/1744806917719804.
10
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies.神经系统疾病中的NLRP3炎性小体:从功能到治疗
Front Cell Neurosci. 2017 Mar 9;11:63. doi: 10.3389/fncel.2017.00063. eCollection 2017.